(Q40307417)

19 September 2017

title

Biopharmaceutical benchmarks 2006. (English)

1 reference

19 September 2017

Gary Walsh

1 reference

19 September 2017

publication date

1 July 2006

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

19 September 2017

page(s)

769-776

1 reference

The therapeutic antibodies market to 2008.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Recombinant protein therapeutics--success rates, market trends and values to 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Yeast secretory expression of insulin precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Therapeutic insulins and their large-scale manufacture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Dermal and transdermal drug delivery systems: current and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Transdermal protein delivery by a coadministered peptide identified via phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Oral delivery of peptide drugs: barriers and developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Drug delivery in biotechnology: present and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

The humanization of N-glycosylation pathways in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Biopharmaceutical production in plants: problems, solutions and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Modification of plant N-glycans processing: the future of producing therapeutic protein by transgenic plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Advances in the production of human therapeutic proteins in yeasts and filamentous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Developing baculovirus-insect cell expression systems for humanized recombinant glycoprotein production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Optimization of humanized IgGs in glycoengineered Pichia pastoris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Competitive bioreactor hens on the horizon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Production of human monoclonal antibody in eggs of chimeric chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Gendicine: the first commercial gene therapy product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Gene therapy: twenty-first century medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Ribozyme: a clinical tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

RNA interference: potential therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

RNAi-mediated gene silencing in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Reaction to the paper: interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Acquired red cell aplasia in association with the use of recombinant erythropoietin in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Aptamers--basic research, drug development, and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Aptamers: an emerging class of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Artificial, non-antibody binding proteins for pharmaceutical and industrial applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Engineering novel binding proteins from nonimmunoglobulin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Making sense of antisense

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

Biotech drug market steadily expands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

7 January 2021

Biopharmaceutical benchmarks--2003

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

7 January 2021

https://api.crossref.org/works/10.1038%2FNBT0706-769

1 reference

7 January 2021

Seminal vesicle production and secretion of growth hormone into seminal fluid

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

7 January 2021

Sandoz sues FDA over delay in first biogeneric approval

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

7 January 2021

Micelle-associated protein in epoetin formulations: aA risk factor for immunogenicity?

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

7 January 2021

TeGenero fiasco prompts regulatory rethink

1 reference

https://api.crossref.org/works/10.1038%2FNBT0706-769

7 January 2021

Identifiers

DOI

10.1038/NBT0706-769

1 reference

Dimensions Publication ID

19 September 2017

1016042105

0 references

1 reference